☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Hidradenitis Suppurativa
AbbVie & Eisai's Humira (adalimumab) Receives Approval for Hidradenitis Suppurativa in Japan
February 22, 2019
Load more...
Back to Home